Biotech - Spark Newswire

2 minute read

HTG Says Completes Product Design Lock For Planned Transcriptome Panel, Announces Signing Of 3 Early Adopter Program Collaboration Agreements

Today, 9:30 AM

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has completed product design lock for the HTG Transcriptome Panel and

HTGM

2 minute read

FDA
News

Lipocine Announces FDA Clears LPCN 1154 IND Application for a Phase 2 Postpartum Depression Study

By Benzinga Newsdesk

Today, 9:30 AM

Lipocine Inc. (NASDAQ:LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the U.S. Food and Drug Administration ("FDA") has cleared the

LPCN

2 minute read

Twist Bioscience Collaborates With Regeneron For Production Of Genotyping By Sequencing Panel To Enable Diverse Genome-Wide Screening; Terms Not Disclosed

By Bill Haddad

Today, 9:30 AM

Population Genetics Sequencing Panel Incorporates Global Genetic Variations for Superior Study of Disease and Target Discovery -- Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed

REGN

1 minute read

Why Is Enochian BioSciences (ENOB) Stock Surging Today?

By Vandana Singh

Today, 9:30 AM

The FDA has accepted Enochian BioSciences Inc’s (NASDAQ:ENOB) pre-IND (Investigational New Drug) request for a potential functional cure or treatment of…

ENOB

1 minute read

Why Novavax Stock Is Moving Today

By Henry Khederian

Today, 9:30 AM

Novavax, Inc. (NASDAQ: NVAX) shares are trading higher by 9.8% at $230.25 Monday morning after the company announced positive Phase 3 trial results for its COVID-19 vaccine.

NVAX

1 minute read

iTeos Therapeutics Stock Surges On $2.1B Development Pact For EOS-448 With GSK

By Vandana Singh

Today, 9:30 AM

iTeos Therapeutics (NASDAQ:ITOS) and GlaxoSmithKline plc (NYSE:GSK) have agreed to co-develop and co-commercialize EOS-448, an anti-TIGIT monoclonal antibody. Under the terms of…

GSK

1 minute read

Johnson & Johnson Building Case With New Patient Survival Data For Darzalex In Multiple Myeloma

By Vandana Singh

Today, 9:30 AM

Janssen Pharmaceutical, a unit of Johnson & Johnson (NYSE:JNJ), announced overall survival (OS) results from the Phase 3 MAIA study evaluating the…

BMY

1 minute read

Ascendis Pharma’s TransCon hGH FDA Review Pushed Backed By Three Months

By Vandana Singh

Today, 9:30 AM

The FDA has extended the ongoing review of the marketing application of Ascendis Pharma A/S’s (NASDAQ:ASND) TransCon hGH (lonapegsomatropin) for the treatment…

ASND

1 minute read

Sorrento, Mayo Clinic Ink Research Pact For Ipilimumab-Delivering Sofusa In Melanoma Patients

By Vandana Singh

Today, 9:30 AM

Sorrento Therapeutics Inc (NASDAQ:SRNE) entered into a research collaboration agreement with Mayo Clinic to conduct human clinical proof of concept studies…

SRNE

2 minute read

AIM ImmunoTech Highlights Ampligen Featured in Peer-Reviewed Journal Cancers As A Potential Therapy For Cancer Patients With SARS-CoV-2

By Bill Haddad

Today, 9:30 AM

AIM ImmunoTech Inc. (NYSE:AIM) today announced that its drug Ampligen has been featured in a publication containing state-of-the-art methodologies in the peer-reviewed medical journal Cancers as a potential

AIM